DE60044117D1 - Stabile Zusammensetzung für eine orale Dosis mit verlängerter Freisetzung enthaltend Pseudoephedrin and Desloratadin - Google Patents

Stabile Zusammensetzung für eine orale Dosis mit verlängerter Freisetzung enthaltend Pseudoephedrin and Desloratadin

Info

Publication number
DE60044117D1
DE60044117D1 DE60044117T DE60044117T DE60044117D1 DE 60044117 D1 DE60044117 D1 DE 60044117D1 DE 60044117 T DE60044117 T DE 60044117T DE 60044117 T DE60044117 T DE 60044117T DE 60044117 D1 DE60044117 D1 DE 60044117D1
Authority
DE
Germany
Prior art keywords
desloratadine
composition containing
sustained release
release composition
oral sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60044117T
Other languages
English (en)
Inventor
Jim H Kou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60044117(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE60044117D1 publication Critical patent/DE60044117D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60044117T 1999-12-20 2000-12-20 Stabile Zusammensetzung für eine orale Dosis mit verlängerter Freisetzung enthaltend Pseudoephedrin and Desloratadin Expired - Lifetime DE60044117D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17283699P 1999-12-20 1999-12-20

Publications (1)

Publication Number Publication Date
DE60044117D1 true DE60044117D1 (de) 2010-05-20

Family

ID=22629437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60044117T Expired - Lifetime DE60044117D1 (de) 1999-12-20 2000-12-20 Stabile Zusammensetzung für eine orale Dosis mit verlängerter Freisetzung enthaltend Pseudoephedrin and Desloratadin

Country Status (38)

Country Link
US (2) US6979463B2 (de)
EP (2) EP2196195A3 (de)
JP (3) JP5042403B2 (de)
KR (2) KR100936572B1 (de)
CN (3) CN1211079C (de)
AR (1) AR027033A1 (de)
AT (1) ATE463240T1 (de)
AU (4) AU2277101A (de)
BR (1) BR0006403A (de)
CA (1) CA2329217C (de)
CO (1) CO5251435A1 (de)
CY (1) CY1110693T1 (de)
CZ (1) CZ302860B6 (de)
DE (1) DE60044117D1 (de)
DK (1) DK1112738T3 (de)
EC (1) ECSP003836A (de)
EG (1) EG23759A (de)
ES (1) ES2341751T3 (de)
HK (1) HK1034453A1 (de)
HU (1) HUP0004988A3 (de)
ID (1) ID28675A (de)
IL (1) IL140450A (de)
MX (1) MXPA00013037A (de)
MY (1) MY130773A (de)
NO (1) NO331645B1 (de)
NZ (1) NZ509028A (de)
PE (1) PE20010982A1 (de)
PL (1) PL211573B1 (de)
PT (1) PT1112738E (de)
RU (2) RU2303440C2 (de)
SA (2) SA06270069B1 (de)
SG (1) SG109438A1 (de)
SI (1) SI1112738T1 (de)
SK (1) SK287684B6 (de)
TR (1) TR200003787A2 (de)
TW (1) TWI225414B (de)
WO (1) WO2001045668A2 (de)
ZA (1) ZA200007715B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
JP2004534820A (ja) * 2001-06-20 2004-11-18 シェーリング　コーポレイション 鼻うっ血および鼻閉塞の処置のための抗ヒスタミン薬
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CA2476201C (en) 2002-02-21 2009-09-01 Biovail Laboratories Incorporated Modified release formulations of at least one form of tramadol
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US20040229896A1 (en) * 2003-03-12 2004-11-18 Toth Zoltan G. Stable pharmaceutical compositions of desloratadine
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US20070116764A1 (en) * 2003-12-01 2007-05-24 Shigeyuki Marunaka Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing
JP2008517938A (ja) * 2004-10-25 2008-05-29 シェーリング コーポレイション 呼吸器障害を処置するために他の活性剤と組み合わせたｍ１レセプターアンタゴニストおよび／またはｍ３レセプターアンタゴニスト
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US8068991B2 (en) 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
FR2894143B1 (fr) 2005-12-01 2008-05-02 Pierre Fabre Medicament Sa Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
SG172664A1 (en) * 2006-06-01 2011-07-28 Schering Plough Healthcare Phenylephrine pharmaceutical formulations and compositions for colonic absorption
CN101472561A (zh) * 2006-06-01 2009-07-01 先灵公司 去氧肾上腺素脉冲释放制剂和药物组合物
AU2007254826B2 (en) * 2006-06-01 2013-10-24 Merck Sharp & Dohme Corp. Pharmaceutical compositions for sustained release of phenyephrine
MX2009000320A (es) * 2006-07-11 2009-06-05 Mutual Pharmaceutical Co Formulaciones de liberacion controlada.
CN101848706A (zh) * 2007-06-01 2010-09-29 先灵-普劳健康护理产品公司 包含底物和含活性成分和聚乙烯醇的包衣的药用组合物
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
EP3045043B1 (de) 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
WO2010143202A1 (en) * 2009-06-09 2010-12-16 Sun Pharmaceutical Industries Ltd. Pharmaceutical composition
TR201009396A2 (tr) 2010-11-11 2012-05-21 Bi̇lgi̇ç Mahmut Desloratadin granüller
DE102016107760B4 (de) 2016-04-26 2018-09-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Essbare Funktionsschichten und Überzüge auf Hybridpolymerbasis für Pharmazie und Lebensmittel
US20180187263A1 (en) 2017-01-05 2018-07-05 Iowa State University Research Foundation, Inc. Kits for diagnostic detection and prevention of feedlot bovine respiratory disease
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100000A (en) 1870-02-22 Improved sun-bonnet for horses
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3940485A (en) 1973-12-12 1976-02-24 Levinson Harold N Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds
US4008796A (en) 1974-03-26 1977-02-22 General Concrete Of Canada Limited Control method for feeding items on a conveyor
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4282233B1 (en) 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
HU194864B (en) 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
US4552899A (en) 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4731447A (en) 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4804666A (en) 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
JPS6396126A (ja) 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物
US5089496A (en) 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4777170A (en) 1987-02-03 1988-10-11 Heinrich William A Method to prevent and treat the signs and symptoms of motion sickness
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4863931A (en) 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
US5019591A (en) 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
ZA914764B (en) 1990-06-22 1992-03-25 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use
AU665341B2 (en) 1990-12-18 1996-01-04 Wellcome Foundation Limited, The Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
MX9202350A (es) 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
ES2042421B1 (es) 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
IT1264517B1 (it) 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
JP2646972B2 (ja) 1993-11-01 1997-08-27 日本電気株式会社 多ビットメモリ
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
JP2000505104A (ja) * 1996-10-31 2000-04-25 シェーリング コーポレイション 喘息の治療のためのロラタジンおよび充血除去剤を含む組成物
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6506767B1 (en) 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
CA2307790A1 (en) 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
AU741201B2 (en) 1998-07-10 2001-11-22 Merck Sharp & Dohme Corp. 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6) cyclohepta (1,2-b)pyridine oral compositions
US6423721B1 (en) 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6051585A (en) 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001056571A1 (en) 2000-02-03 2001-08-09 Schering Corporation Treating allergic and inflammatory conditions
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
KR20020093982A (ko) 2000-05-19 2002-12-16 알콘, 인코퍼레이티드 알레르기성 질환 치료를 위한 아닐린 디설파이드 유도체
US6599913B1 (en) 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions

Also Published As

Publication number Publication date
ECSP003836A (es) 2002-02-25
EP1112738A3 (de) 2001-07-18
PL344715A1 (en) 2001-07-02
US7820199B2 (en) 2010-10-26
CN101081224B (zh) 2012-05-30
CZ20004812A3 (cs) 2001-08-15
EP1112738B1 (de) 2010-04-07
EP1112738A2 (de) 2001-07-04
EP2196195A3 (de) 2012-02-29
SA01210741A (ar) 2005-12-03
NO20006504D0 (no) 2000-12-20
KR20110028326A (ko) 2011-03-17
NZ509028A (en) 2002-12-20
CN1301534A (zh) 2001-07-04
HK1034453A1 (en) 2001-10-26
EP2196195A2 (de) 2010-06-16
ID28675A (id) 2001-06-21
CN1679569A (zh) 2005-10-12
US20060159761A1 (en) 2006-07-20
IL140450A (en) 2011-11-30
RU2007104095A (ru) 2008-08-10
TWI225414B (en) 2004-12-21
SK19672000A3 (sk) 2001-09-11
PE20010982A1 (es) 2001-09-28
RU2423106C9 (ru) 2012-06-27
AU2009200460A1 (en) 2009-02-26
KR20010062542A (ko) 2001-07-07
AU2005203771A1 (en) 2005-09-15
CN101081224A (zh) 2007-12-05
BR0006403A (pt) 2001-07-17
RU2303440C2 (ru) 2007-07-27
ZA200007715B (en) 2001-06-20
KR100936572B1 (ko) 2010-01-13
CY1110693T1 (el) 2015-06-10
WO2001045668A3 (en) 2001-12-13
AU2009200460B2 (en) 2012-01-19
PL211573B1 (pl) 2012-05-31
HUP0004988A2 (hu) 2002-11-28
ATE463240T1 (de) 2010-04-15
IL140450A0 (en) 2002-02-10
CO5251435A1 (es) 2003-02-28
CZ302860B6 (cs) 2011-12-21
PT1112738E (pt) 2010-06-04
JP2012224642A (ja) 2012-11-15
JP5042403B2 (ja) 2012-10-03
JP2001172174A (ja) 2001-06-26
AU7244300A (en) 2001-06-21
RU2423106C2 (ru) 2011-07-10
SK287684B6 (sk) 2011-06-06
SA01210741B1 (ar) 2006-10-31
HU0004988D0 (de) 2001-02-28
CN1211079C (zh) 2005-07-20
DK1112738T3 (da) 2010-06-28
SI1112738T1 (sl) 2010-07-30
US20030086971A1 (en) 2003-05-08
US6979463B2 (en) 2005-12-27
WO2001045668A2 (en) 2001-06-28
ES2341751T3 (es) 2010-06-28
SA06270069B1 (ar) 2009-06-07
MXPA00013037A (es) 2003-06-19
TR200003787A3 (tr) 2001-07-23
AU781924B2 (en) 2005-06-23
KR101234940B1 (ko) 2013-02-19
EG23759A (en) 2007-08-08
HUP0004988A3 (en) 2008-04-28
MY130773A (en) 2007-07-31
JP2008081510A (ja) 2008-04-10
NO20006504L (no) 2001-06-21
NO331645B1 (no) 2012-02-13
CA2329217A1 (en) 2001-06-20
TR200003787A2 (tr) 2001-07-23
CA2329217C (en) 2006-10-31
SG109438A1 (en) 2005-03-30
AU2277101A (en) 2001-07-03
AR027033A1 (es) 2003-03-12

Similar Documents

Publication Publication Date Title
DE60044117D1 (de) Stabile Zusammensetzung für eine orale Dosis mit verlängerter Freisetzung enthaltend Pseudoephedrin and Desloratadin
NO20022334L (no) Ny sammensetning og anvendelse
DE60025198D1 (de) Stabile biozidale zusammensetzung
ATE313315T1 (de) Stabile antibakterielle mundpflegezusammensetzung enthaltend hydriertes lupulon
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
CY2013032I1 (el) Συζυγη της εξενδινης-4 και η φαρμακευτικη τους χρηση
CY2007031I2 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
IS6411A (is) Kaspasa tálmar og notkun þeirra
EE200300247A (et) Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
NO20025158L (no) Lipidpreparat og anvendelse derav
DE60037282D1 (de) Zahnpflegemittel
NO20010804D0 (no) Muskariniske agonister og antagonister
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
DE60125981D1 (de) Amlodipin in form der freien base
NO20030998D0 (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
ATE450255T1 (de) Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
ATE281775T1 (de) Stabile ein/auszugseinrichtung
ATE317386T1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE50106974D1 (de) Aufbereitungs- und applikationsvorrichtung für implantatmaterialien
FI20002452A0 (fi) Menetelmät hammashoitokoneen vesilinjojen desinfioimiseksi ja hammashoitokoneen vesilinjojen desinfiointijärjestelyt
EE200300138A (et) Epinastiini ja pseudoefedriini sisaldavad farmatseutilised kompositsioonid
NO20025135L (no) Antihypertensive midler og anvendelse
SE0004405D0 (sv) New composition and use
FI19992584A (fi) Voidemainen koostumus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition